Intracranial atherosclerosis

Dual antiplatelet therapy
This treatment may work better in patients who do not have elevated serum lipoprotein-associated phospholipase A2 (Lp-PLA2) levels, an enzyme that is highly expressed within the necrotic core of atherosclerotic plaque and may be associated with symptomatic plaques.